#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Selective polysaccharide antibody deficiency Microscopic polyangiitis Thyroid cancer metastatic Gaucher's disease type III Tuberous sclerosis complex Desmoid tumour Allogenic stem cell transplantation Immune-mediated myasthenia gravis Colitis ulcerative Oesophageal atresia Oropharyngeal cancer recurrent Hypocalcaemia Tourette's disorder Cystic fibrosis gastrointestinal disease Oesophageal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Diagnostics Adrenogenital syndrome – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Hereditary angioedema – Treatment Cholangitis sclerosing – Treatment Chordoma – Trials in Disease Short-bowel syndrome – Trials in Disease Prader-Willi syndrome – Basic Information Tuberous sclerosis complex – Life with Disease Haemophilia B without inhibitors – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paroxetine Hydrochloride Tafasitamab Baclofen Corifollitropin Alfa Abc-23B-116 Img-007 Tofersen Denosumab Flutamide Lovastatin Benzalkonium Chloride OMTX705 [18F]Fluoro-Peg-Folate Lysine Aspirin L-METHIONINE Dapansutrile Cetrimide Andexanet Alfa Tocotrienol Atogepant More therapies…

    Learn about Your Condition

    Thrombectomy Narcolepsy Systemic candida Herpes zoster Glioblastoma Post procedural hypotension Follicular lymphoma stage IV Triple positive breast cancer Decreased appetite Metastatic neoplasm Notalgia paraesthetica Neuroendocrine carcinoma Metastases to peritoneum Chronic hepatitis C Bladder cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Noe LGA Gesundheit Region Mitte GmbH

Noe LGA Gesundheit Region Mitte GmbH

Alter Ziegelweg 10, St. Poelten, 3430, Austria

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Nivolumab
    • Relatlimab
    Austria Belgium Czechia Finland France Germany +5

  • Efficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • ORG-129
    Austria Belgium Czechia Denmark France Germany +4

  • A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Austria Belgium Czechia Denmark France Germany +8

  • A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Aciclovir
    • Linvoseltamab
    • Bortezomib
    Austria Belgium Czechia France Germany Greece +4

  • Study on Alkaline Phosphatase to Prevent Inflammation and Kidney Injury in Patients Undergoing Open-Heart Surgery

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    Investigated Drugs:
    • Alkaline Phosphatase, Bovine
    Austria Belgium

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Lutikizumab
    • Adalimumab
    Austria Belgium Bulgaria Croatia Estonia France +12

  • Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia France Hungary +3

  • Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Atezolizumab
    • Pertuzumab
    • Trastuzumab
    Austria Belgium Germany Italy Romania Spain

  • Study of SYM024, SYM023, and SYM025 in Adults with Advanced Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Expression

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Sym023
    • Sym024
    • Sym025
    Austria Belgium France Hungary Italy Romania +1

  • Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Vibostolimab
    • Pembrolizumab
    Austria Belgium France Germany Ireland Italy +3
Previous Page
1 … 3 4 5 6 7 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!